Gene · 10487
Papers1,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAP1-Mediated m6A modification of RRM2 suppresses tumor-associated M2 macrophage polarization and colorectal cancer growth. | Cell Mol Life Sci | 2026 | 41483049 | PubTator, text mining | PubMed |
| Translational control in plants: from basic mechanisms to environmental and developmental responses. | Plant J | 2026 | 41481835 | PubTator, text mining | PubMed |
| Targeting platelet-mediated CAP-1 upregulation in colorectal cancer: Mechanisms and small-molecule inhibitor development. | Pharmacol Res | 2026 | 41352405 | PubTator, text mining | PubMed |
| Novel trinucleotide mRNA capping reagents: improved synthetic route and efficient cotranscriptional incorporation in mRNA. | RNA | 2026 | 41260898 | PubTator, text mining | PubMed |
| Unraveling spatiotemporal dynamics in transdiagnosis subtypes of major depressive disorder and bipolar disorder: insights from co-activation patterns and treatment response. | Mol Psychiatry | 2026 | 41198946 | PubTator, text mining | PubMed |
| mRNA vaccines transform personalized lung cancer treatment. | Front Immunol | 2025 | 41766818 | PubTator, text mining | PubMed |
| VEGF-A isoforms induce the expression of APLN in endothelial cells during human prenatal lung development. | Front Cell Dev Biol | 2025 | 41660010 | PubTator, text mining | PubMed |
| Assay development and screening of inhibitors targeting the SARS-CoV-2 2'-O-methyltransferase NSP16. | Pharm Sci Adv | 2025 | 41550643 | PubTator, text mining | PubMed |
| Resistin in cardiac diseases: from molecular mechanisms to clinical implications. | Front Endocrinol (Lausanne) | 2025 | 41347124 | PubTator, text mining | PubMed |
| Functions and applications of enzymes in nucleic acid nanotechnology. | J Nanobiotechnology | 2025 | 41327310 | PubTator, text mining | PubMed |
| High Expression of Actin Binding Proteins Predicts Hematogenous Metastases in Non-Small Cell Lung Cancer. | Asian Pac J Cancer Prev | 2025 | 41312930 | PubTator, text mining | PubMed |
| mRNA vaccines: immunogenicity and quality characteristics. | J Nanobiotechnology | 2025 | 41310620 | PubTator, text mining | PubMed |
| Cap1 forms a cyclic tetra-adenylate-induced membrane pore during the type III-A CRISPR-Cas immune response. | bioRxiv | 2025 | 41292787 | PubTator, text mining | PubMed |
| mRNA caps accumulate in stress granules and are essential for their formation. | Cell Mol Life Sci | 2025 | 41288727 | PubTator, text mining | PubMed |
| Synthesis, Incorporation, and Translation Properties of Threose Nucleic Acid Modified Trinucleotide Cap Analogs. | ACS Omega | 2025 | 41244500 | PubTator, text mining | PubMed |
| Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors. | Mol Ther Nucleic Acids | 2025 | 41210587 | PubTator, text mining | PubMed |
| Derivation and external validation of community-acquired pneumonia subphenotypes in Southeast Asia: a secondary analysis of prospective cohort studies. | EClinicalMedicine | 2025 | 41209652 | PubTator, text mining | PubMed |
| From development to regeneration: the endothelial interface in lung injury and repair. | Am J Physiol Lung Cell Mol Physiol | 2025 | 41071714 | PubTator, text mining | PubMed |
| Identification and validation of immune-associated gene signatures for prognostic prediction in acute myeloid leukemia. | Medicine (Baltimore) | 2025 | 41029105 | PubTator, text mining | PubMed |
| Mind the cap: Detecting degradation impurities in synthetic mRNAs. | Mol Ther Nucleic Acids | 2025 | 41017812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10487/papers?page=3